LANSGROVE LIMITED
Company number 09096325 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: LANSGROVE LIMITED
1. Financial Health Score: F
Explanation: The company has been placed into Liquidation. Regardless of the historical financial metrics showing positive net assets, a status of Liquidation indicates that the business has suffered a terminal financial event. The patient has, unfortunately, passed away. While the most recent balance sheet (April 2023) shows a pulse—positive net assets of £484,809—the legal status of the company confirms that it is no longer a going concern and is undergoing a formal winding-up process.
2. Key Vital Signs
- Heartbeat (Company Status): Flatline. The company is officially in Liquidation. Operations have ceased, and the company is being dismantled to settle debts.
- Blood Pressure (Liquidity): Dangerously Low. While the current ratio appears superficially healthy at 1.15 (Current Assets £4.24M vs Current Liabilities £3.67M), this is heavily distorted by "blocked arteries." Trade debtors have ballooned to £3.3M, while actual cash in the bank has plummeted by 47% to just £230,799. The company lacks the liquid cash reserves needed to survive a financial shock.
- Weight (Debt Burden): Obese. Total liabilities stand at £3.67M, overwhelmingly driven by trade creditors (£2.97M). The business owes significantly more in the short term than it holds in cash.
- Immune System (Cash Reserves): Compromised. Cash fell from £436,347 in 2022 to £230,799 in 2023. This rapid depletion of reserves left the business vulnerable to insolvency.
- Artificial Life Support (Tax Income): The accounts show a negative tax expense—meaning the company recorded tax income of £193,889. This is likely due to R&D tax credits or similar reliefs common in the development sector. While this artificially boosted retained earnings, it masks the underlying operational cash generation.
3. Symptoms Analysis
- Symptoms of Severe Cash Flow Blockages: The most alarming symptom is the massive disconnect between sales (evidenced by the £3.3M in trade debtors) and cash collection. The business was clearly struggling to get clients to pay. In the construction and development sector, unpaid invoices are often a precursor to bad debt and disputes, which can quickly choke a company's cash flow to death.
- Swelling Short-Term Obligations: Trade creditors nearly doubled from £1.43M to £2.97M. This suggests the company was robbing Peter to pay Paul—taking on new supplier credit to finish projects while unable to pay existing bills.
- Administrative Neglect: Both the annual accounts and the confirmation statement are officially overdue. This is a common symptom when a company enters liquidation; the directors often stop performing routine administrative "hygiene" as the business winds down.
- Directors' Loan: The directors owed the company £107,115. While noted as repaid post-year-end, this represents a significant sum relative to the company's dwindling cash position and suggests intermingling of personal and corporate finances.
4. Diagnosis
Terminal Insolvency due to Cash Flow Asphyxiation.
Although the April 2023 balance sheet suggested the company had net assets of £484,809, this was an illusion based on the assumption that the £3.3M in trade debtors would eventually convert to cash. In reality, the company was bleeding cash and suffocating under short-term creditor pressure. The transition into Liquidation confirms that these debtors were likely unrealizable or tied up in disputes, and the trade creditors could not be serviced. The reliance on tax rebates (rather than trading profit) for equity growth further highlights that the core business engine had stalled.
5. Recommendations
As the company is in Liquidation, recommendations for business improvement are no longer applicable. Instead, the following actions are relevant for the stakeholders:
- For the Liquidator: Prioritize the collection of the £3.3M trade debtors. This is the only significant asset that may provide a return to creditors. A forensic review of why these invoices were unpaid at the point of liquidation is essential.
- For Creditors: Do not expect full repayment. With only £230k in cash and £3.67M in immediate debts, unsecured creditors will likely face significant losses. Submit claims promptly to the appointed liquidator.
- For the Directors (Guy Plant, Scott Rodell, Ross Gorton): Fully cooperate with the liquidator. Given the overdue filings and the liquidation status, ensure all company records are handed over promptly to avoid any accusations of wrongful or fraudulent trading, particularly regarding the rapid increase in trade creditors and the directors' loan account.
- For the Parent Company (Lansgrove Group Limited): Consolidate any remaining group-level assets and write off the investment in this subsidiary. Review other subsidiaries for similar symptoms of cash flow blockages and excessive creditor reliance.